Unbiased Analysis of Today's Healthcare Issues

How Scott Gottlieb is transforming the FDA

The Economist has an article on the evolution of FDA regulation of pharmaceutical treatments.  Brining a drug to market costs billions of dollars.  FDA commissioner Scott Gottlieb aims to cut this cost by expediting the drug approval process in three key ways. First, he wants the agency to rethink how much information the FDA demands […]

Read the rest of this entry »